The easily obtained biomarkers may be useful for systematic evaluation and stratification of SSc patients, especially to identify those at risk of pulmonary hypertension. PubMed, Arthritis Care Res (Hoboken), 01/20/2015. (Also see: Scleroderma Cardiac Involvement and Scleroderma Biomarkers)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.